<p>2025 年 12 月 9 日，Akero Therapeutics, Inc. 宣佈在完成合並後對其董事會和高管團隊進行了重大變更。所有之前的董事和高管均已辭職，並根據合併協議進行了新的任命。</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>個人</strong></td>
<td>Andrew Cheng, M.D., Ph.D.</td>
<td>Jane Henderson</td>
<td>Seth L. Harrison, M.D., Ph.D.</td>
<td>Graham L. Walmsley, M.D., Ph.D.</td>
<td>Yuan Xu, Ph.D.</td>
<td>Mark T. Iwicki</td>
<td>Tomas Heyman</td>
<td>Judy Chou, Ph.D.</td>
<td>Scott Gangloff</td>
<td>Patrick Lamy</td>
<td>Timothy Rolph, D.Phil.</td>
<td>William White, J.D.</td>
<td>Catriona Yale</td>
<td>Jonathan Young, J.D., Ph.D.</td>
<td>John Kuckelman</td>
<td>Daniel Bohsen</td>
<td>Steve Benz</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>董事/高管</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>董事</td>
<td>董事/總裁兼財務主管</td>
<td>董事</td>
</tr>
<tr>
<td><strong>變更類型</strong></td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>被移除</td>
<td>被移除</td>
<td>被移除</td>
<td>被移除</td>
<td>被移除</td>
<td>被移除/重新任命</td>
<td>任命</td>
<td>任命</td>
<td>任命</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>重新任命為助理財務主管</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
<tr>
<td><strong>背景詳情</strong></td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
</tr>
<tr>
<td><strong>董事會/委員會角色變更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
<p>原始 SEC 文件：Akero Therapeutics, Inc. [ AKRO ] - 8-K -2025 年 12 月 09 日
<strong>免責聲明</strong></p>
<p>這是一個由人工智能生成的摘要，可能包含不準確之處。請考慮與來源核實重要信息。請注意，此摘要僅基於向 SEC 提交的文件。</p>

AKRO

<p>Akero Therapeutics 在 2025 年 12 月 9 日的合併後宣佈了重大董事會和高管變動。所有之前的董事和高管均已辭職，並根據合併協議進行了新的任命。這些變動在合併時生效，但替換的具體細節未予披露</p>

<p>On December 9, 2025, Akero Therapeutics, Inc. announced significant changes to its board and executive team following the consummation of a merger. All previous directors and executive officers resigned, and new appointments were made as per the merger agreement.</p>
<div class="lb-trans"><p>2025 年 12 月 9 日，Akero Therapeutics, Inc. 宣佈在完成合並後對其董事會和高管團隊進行了重大變更。所有之前的董事和高管均已辭職，並根據合併協議進行了新的任命。</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Individual</strong></td>
<td>Andrew Cheng, M.D., Ph.D.</td>
<td>Jane Henderson</td>
<td>Seth L. Harrison, M.D., Ph.D.</td>
<td>Graham L. Walmsley, M.D., Ph.D.</td>
<td>Yuan Xu, Ph.D.</td>
<td>Mark T. Iwicki</td>
<td>Tomas Heyman</td>
<td>Judy Chou, Ph.D.</td>
<td>Scott Gangloff</td>
<td>Patrick Lamy</td>
<td>Timothy Rolph, D.Phil.</td>
<td>William White, J.D.</td>
<td>Catriona Yale</td>
<td>Jonathan Young, J.D., Ph.D.</td>
<td>John Kuckelman</td>
<td>Daniel Bohsen</td>
<td>Steve Benz</td>
</tr>
<tr>
<td><strong>Role</strong></td>
<td>Director/Executive Officer</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Director</td>
<td>Executive Officer</td>
<td>Executive Officer</td>
<td>Executive Officer</td>
<td>Executive Officer</td>
<td>Executive Officer</td>
<td>Executive Officer</td>
<td>Director</td>
<td>Director/President and Treasurer</td>
<td>Director</td>
</tr>
<tr>
<td><strong>Type of Change</strong></td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Resigned</td>
<td>Removed</td>
<td>Removed</td>
<td>Removed</td>
<td>Removed</td>
<td>Removed</td>
<td>Removed/Re-appointed</td>
<td>Appointed</td>
<td>Appointed</td>
<td>Appointed</td>
</tr>
<tr>
<td><strong>Effective Date</strong></td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
<td>Effective Time of Merger</td>
</tr>
<tr>
<td><strong>Reason</strong></td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
<td>Merger Agreement</td>
</tr>
<tr>
<td><strong>Replacement Info</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Re-appointed as Assistant Treasurer</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
</tr>
<tr>
<td><strong>Background Details</strong></td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Board/Committee Role Changes</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>個人</strong></td>
<td>Andrew Cheng, M.D., Ph.D.</td>
<td>Jane Henderson</td>
<td>Seth L. Harrison, M.D., Ph.D.</td>
<td>Graham L. Walmsley, M.D., Ph.D.</td>
<td>Yuan Xu, Ph.D.</td>
<td>Mark T. Iwicki</td>
<td>Tomas Heyman</td>
<td>Judy Chou, Ph.D.</td>
<td>Scott Gangloff</td>
<td>Patrick Lamy</td>
<td>Timothy Rolph, D.Phil.</td>
<td>William White, J.D.</td>
<td>Catriona Yale</td>
<td>Jonathan Young, J.D., Ph.D.</td>
<td>John Kuckelman</td>
<td>Daniel Bohsen</td>
<td>Steve Benz</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>董事/高管</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>董事</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>董事</td>
<td>董事/總裁兼財務主管</td>
<td>董事</td>
</tr>
<tr>
<td><strong>變更類型</strong></td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>辭職</td>
<td>被移除</td>
<td>被移除</td>
<td>被移除</td>
<td>被移除</td>
<td>被移除</td>
<td>被移除/重新任命</td>
<td>任命</td>
<td>任命</td>
<td>任命</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
<td>合併生效時間</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
<td>合併協議</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>重新任命為助理財務主管</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
<tr>
<td><strong>背景詳情</strong></td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
<td>不適用</td>
</tr>
<tr>
<td><strong>董事會/委員會角色變更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
</div><p>Original SEC Filing: Akero Therapeutics, Inc. [ AKRO ] - 8-K - Dec. 09, 2025
<strong>Disclaimer</strong></p>
<div class="lb-trans"><p>原始 SEC 文件：Akero Therapeutics, Inc. [ AKRO ] - 8-K -2025 年 12 月 09 日
<strong>免責聲明</strong></p>
</div><p>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</p>
<div class="lb-trans"><p>這是一個由人工智能生成的摘要，可能包含不準確之處。請考慮與來源核實重要信息。請注意，此摘要僅基於向 SEC 提交的文件。</p>
</div>

Akero Therapeutics 宣佈合併後董事會和管理層的變動